V1 sact_drug_detail
6,385,827 rows · 11 columns
| MERGED_DRUG_DETAIL_ID | MERGED_CYCLE_ID | ORG_CODE_OF_DRUG_PROVIDER | ACTUAL_DOSE_PER_ADMINISTRATION | OPCS_DELIVERY_CODE | ADMINISTRATION_ROUTE | ADMINISTRATION_DATE | DRUG_GROUP | MERGED_PATIENT_ID | MERGED_TUMOUR_ID | MERGED_REGIMEN_ID |
|---|---|---|---|---|---|---|---|---|---|---|
| 16677794 | 330030391 | EE801 | 0 | X721 | 1 | 2016-09-19 | STEROID | 330000649 | 330000120 | 330000258 |
| 16677795 | 330030391 | EGT | 800 | X721 | 2 | 2016-09-19 | IRINOTECAN | 330000649 | 330000120 | 330000258 |
| 16677796 | 330030391 | EKP02 | 3600 | null | 1 | 2016-09-19 | CISPLATIN | 330000649 | 330000120 | 330000258 |
| 16677797 | 330030391 | EEX02 | 20 | null | 2 | 2016-09-20 | TRABECTEDIN | 330000649 | 330000120 | 330000258 |
| 16677798 | 330030392 | EWR01 | 4640 | X724 | 1 | 2015-04-24 | ETOPOSIDE | 330000666 | 330000121 | 330000260 |
| 16677799 | 330030392 | EK1EN | 0 | X721 | 1 | 2015-04-24 | STEROID | 330000666 | 330000121 | 330000260 |
| 16677800 | 330030392 | ED301 | 400 | null | 1 | 2015-04-24 | IRINOTECAN | 330000666 | 330000121 | 330000260 |
| 16677801 | 330030392 | EK1PP | 3200 | null | 1 | 2015-04-25 | IFOSFAMIDE | 330000666 | 330000121 | 330000260 |
| 16677802 | 330030392 | EK1EN | 300 | X724 | 1 | 2015-04-25 | ETOPOSIDE | 330000666 | 330000121 | 330000260 |
| 16677803 | 330030392 | EEX02 | 200 | X729 | 1 | 2015-04-26 | LENALIDOMIDE | 330000666 | 330000121 | 330000260 |
| 16677804 | 330030392 | EC4 | 72 | X721 | 1 | 2015-04-28 | MITOTANE | 330000666 | 330000121 | 330000260 |
| 16677805 | 330030392 | EJU04 | 8 | X721 | 2 | 2015-04-28 | EPIRUBICIN | 330000666 | 330000121 | 330000260 |
| 16677806 | 330030392 | EJR | 65 | null | 1 | 2015-04-28 | NOT CHEMO | 330000666 | 330000121 | 330000260 |
| 16677807 | 330030392 | EKU09 | 900 | X729 | 1 | 2015-04-28 | RITUXIMAB | 330000666 | 330000121 | 330000260 |
| 16677808 | 330030393 | EUDUU | 170 | null | 1 | 2017-09-25 | CYTARABINE | 330000679 | 330006213 | 330000265 |
| 16677809 | 330030394 | EOI | 120 | x721 | null | 2015-05-19 | CYTARABINE | 330000684 | 330009388 | 330000266 |
| 16677810 | 330030394 | ECL02 | 0 | X723 | 1 | 2015-05-25 | OLARATUMAB | 330000684 | 330009388 | 330000266 |
| 16677811 | 330030394 | ELW | 1.3 | X721 | 1 | 2015-05-26 | IFOSFAMIDE | 330000684 | 330009388 | 330000266 |
| 16677812 | 330030394 | EK1PP | 40 | null | 1 | 2015-05-26 | ETOPOSIDE | 330000684 | 330009388 | 330000266 |
| 16677813 | 330030394 | EK1EN | 180 | null | 1 | 2015-05-26 | ETOPOSIDE | 330000684 | 330009388 | 330000266 |
| 16677814 | 330030394 | EE813 | 1250 | null | 1 | 2015-05-27 | FLUDARABINE | 330000684 | 330009388 | 330000266 |
| 16677815 | 330030394 | EJU04 | 3200 | X729 | null | 2015-05-27 | NOT MATCHED | 330000684 | 330009388 | 330000266 |
| 16677816 | 330030395 | EOI | 300 | X721 | 1 | 2013-09-14 | FLUOROURACIL | 330000732 | 330000135 | 330000290 |
| 16677817 | 330030396 | EOI | 120 | null | 11 | 2017-05-29 | FLUOROURACIL | 330000742 | 330000138 | 330000293 |
| 16677818 | 330030396 | ERA20 | 930 | null | 1 | 2017-05-29 | NOT CHEMO | 330000742 | 330000138 | 330000293 |
| 16677819 | 330030396 | EUZ | 470 | X722 | 2 | 2017-05-30 | OXALIPLATIN | 330000742 | 330000138 | 330000293 |
| 16677820 | 330030396 | EK1PP | 3200 | X721 | 1 | 2017-05-30 | NOT CHEMO | 330000742 | 330000138 | 330000293 |
| 16677821 | 330030396 | EGU02 | 2.8 | X723 | 1 | 2017-05-30 | NOT CHEMO | 330000742 | 330000138 | 330000293 |
| 16677822 | 330030397 | ELW | 156 | X721 | 1 | null | IFOSFAMIDE | 330000750 | 330011120 | 330000299 |
| 16677823 | 330030397 | ECL01 | 120 | X729 | 1 | null | NOT CHEMO | 330000750 | 330011120 | 330000299 |
| 16677824 | 330030397 | EW231 | 3360 | X721 | 1 | null | BEVACIZUMAB | 330000750 | 330011120 | 330000299 |
| 16677825 | 330030399 | EC4 | 200 | X729 | 2 | 2017-01-02 | FLUOROURACIL | 330000773 | 330000145 | 330000309 |
| 16677826 | 330030399 | ECL01 | 930 | X731 | 1 | 2017-01-02 | METHOTREXATE | 330000773 | 330000145 | 330000309 |
| 16677827 | 330030399 | ED301 | 10 | X722 | 1 | 2017-01-02 | NOT CHEMO | 330000773 | 330000145 | 330000309 |
| 16677828 | 330030400 | ECL02 | 66 | null | 2 | 2014-04-06 | ETOPOSIDE | 330000777 | 330000146 | 330000310 |
| 16677829 | 330030400 | ECL01 | 930 | null | 1 | 2014-04-06 | RITUXIMAB | 330000777 | 330000146 | 330000310 |
| 16677830 | 330030400 | EKA | 7120 | X721 | 1 | 2014-04-06 | CARBOPLATIN | 330000777 | 330000146 | 330000310 |
| 16677831 | 330030400 | EW231 | 0.7 | null | 1 | 2014-04-06 | TOPOTECAN | 330000777 | 330000146 | 330000310 |
| 16677832 | 330030403 | ECL02 | 1250 | null | 11 | 2016-09-10 | CISPLATIN | 330000851 | 330000158 | 330000337 |
| 16677833 | 330030403 | EX950 | 225 | X729 | 1 | 2016-09-11 | BENDAMUSTINE | 330000851 | 330000158 | 330000337 |
| 16677834 | 330030405 | EE813 | 250 | null | 1 | null | CYTARABINE | 330000863 | 330000160 | 330000345 |
| 16677835 | 330030405 | EGU02 | 90 | X723 | 1 | null | TRETINOIN | 330000863 | 330000160 | 330000345 |
| 16677836 | 330030405 | ED301 | 1.7 | null | 1 | null | BORTEZOMIB | 330000863 | 330000160 | 330000345 |
| 16677837 | 330030405 | EEI00 | 0.7 | X721 | 1 | null | TOPOTECAN | 330000863 | 330000160 | 330000345 |
| 16677838 | 330030405 | ECL02 | 0.83 | X724 | 1 | null | VINCRISTINE | 330000863 | 330000160 | 330000345 |
| 16677839 | 330030405 | EQ8 | 64 | X721 | 2 | null | BLEOMYCIN | 330000863 | 330000160 | 330000345 |
| 16677840 | 330030405 | EKA | 8 | null | 2 | null | GEMCITABINE | 330000863 | 330000160 | 330000345 |
| 16677841 | 330030405 | ENY00 | 2.4 | X721 | 2 | null | CYCLOPHOSPHAMIDE | 330000863 | 330000160 | 330000345 |
| 16677842 | 330030408 | E1UZ0 | 16000 | null | 1 | 2013-09-02 | CYTARABINE | 330000891 | 330000164 | 330000357 |
| 16677843 | 330030408 | EX950 | 15 | x724 | 1 | 2013-09-02 | ETOPOSIDE | 330000891 | 330000164 | 330000357 |